Korea Investment Corp’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $46.7M | Buy |
74,955
+1,892
| +3% | +$1.29M | 0.09% | 213 |
|
|
2026
Q1 | $56.5M | Buy |
73,063
+3,829
| +6% | +$2.93M | 0.12% | 171 |
|
|
2025
Q4 | $53.4M | Buy |
69,234
+7,777
| +13% | +$5.28M | 0.11% | 180 |
|
|
2025
Q3 | $34.6M | Buy |
61,457
+5,181
| +9% | +$2.93M | 0.07% | 263 |
|
|
2025
Q2 | $29.5M | Sell |
56,276
-9,664
| -15% | -$5.39M | 0.07% | 286 |
|
|
2025
Q1 | $41.8M | Sell |
65,940
-12,283
| -16% | -$8.45M | 0.1% | 200 |
|
|
2024
Q4 | $55.7M | Sell |
78,223
-277
| -0.4% | -$232K | 0.13% | 145 |
|
|
2024
Q3 | $82.5M | Sell |
78,500
-1,318
| -2% | -$1.47M | 0.2% | 107 |
|
|
2024
Q2 | $83.9M | Sell |
79,818
-7,024
| -8% | -$6.81M | 0.21% | 97 |
|
|
2024
Q1 | $83.6M | Sell |
86,842
-13,759
| -14% | -$13.1M | 0.21% | 102 |
|
|
2023
Q4 | $88.4M | Buy |
100,601
+4,805
| +5% | +$3.96M | 0.23% | 92 |
|
|
2023
Q3 | $78.8M | Sell |
95,796
-14,550
| -13% | -$11.4M | 0.23% | 99 |
|
|
2023
Q2 | $79.3M | Buy |
110,346
+2,687
| +2% | +$2.07M | 0.22% | 103 |
|
|
2023
Q1 | $88.5M | Sell |
107,659
-5,146
| -5% | -$3.88M | 0.26% | 92 |
|
|
2022
Q4 | $81.4M | Sell |
112,805
-6,348
| -5% | -$4.68M | 0.26% | 98 |
|
|
2022
Q3 | $82.1M | Buy |
119,153
+10,443
| +10% | +$6.57M | 0.25% | 96 |
|
|
2022
Q2 | $64.3M | Buy |
108,710
+6,369
| +6% | +$4.14M | 0.2% | 127 |
|
|
2022
Q1 | $71.5M | Buy |
102,341
+46,828
| +84% | +$29.6M | 0.18% | 137 |
|
|
2021
Q4 | $35.1M | Sell |
55,513
-30,549
| -35% | -$18.8M | 0.09% | 224 |
|
|
2021
Q3 | $52.1M | Buy |
86,062
+24,016
| +39% | +$14.9M | 0.16% | 162 |
|
|
2021
Q2 | $34.7M | Sell |
62,046
-1,120
| -2% | -$567K | 0.1% | 207 |
|
|
2021
Q1 | $29.9M | Sell |
63,166
-4,634
| -7% | -$2.26M | 0.09% | 206 |
|
|
2020
Q4 | $32.8M | Buy |
67,800
+27,400
| +68% | +$14.8M | 0.1% | 207 |
|
|
2020
Q3 | $22.6M | Buy |
40,400
+8,200
| +25% | +$4.97M | 0.08% | 225 |
|
|
2020
Q2 | $20.1M | Sell |
32,200
-29,500
| -48% | -$16.7M | 0.07% | 236 |
|
|
2020
Q1 | $30.1M | Buy |
61,700
+4,800
| +8% | +$1.98M | 0.13% | 183 |
|
|
2019
Q4 | $21.4M | Buy |
56,900
+15,400
| +37% | +$5.18M | 0.08% | 249 |
|
|
2019
Q3 | $11.5M | Buy |
41,500
+5,700
| +16% | +$1.69M | 0.05% | 339 |
|
|
2019
Q2 | $11.2M | Sell |
35,800
-5,700
| -14% | -$1.9M | 0.05% | 345 |
|
|
2019
Q1 | $17M | Buy |
41,500
+6,288
| +18% | +$2.59M | 0.08% | 266 |
|
|
2018
Q4 | $13.2M | Buy |
35,212
+11,479
| +48% | +$4.2M | 0.07% | 279 |
|
|
2018
Q3 | $9.59M | Sell |
23,733
-19,109
| -45% | -$7.27M | 0.04% | 348 |
|
|
2018
Q2 | $14.8M | Sell |
42,842
-1,860
| -4% | -$582K | 0.07% | 279 |
|
|
2018
Q1 | $15.4M | Buy |
44,702
+13,221
| +42% | +$4.6M | 0.07% | 268 |
|
|
2017
Q4 | $11.8M | Buy |
31,481
+11,900
| +61% | +$4.82M | 0.05% | 318 |
|
|
2017
Q3 | $8.76M | Sell |
19,581
-3,410
| -15% | -$1.62M | 0.04% | 355 |
|
|
2017
Q2 | $11.3M | Buy |
22,991
+22,693
| +7,615% | +$9.93M | 0.05% | 306 |
|
|
2017
Q1 | $115K | Buy |
298
+206
| +224% | +$76.4K | ﹤0.01% | 599 |
|
|
2016
Q4 | $34K | Sell |
92
-8,279
| -99% | -$3.15M | ﹤0.01% | 561 |
|
|
2016
Q3 | $3.37M | Buy |
+8,371
| New | +$3.36M | 0.02% | 457 |
|
|
2016
Q1 | – | Sell |
-21,900
| Closed | -$11.9M | – | 627 |
|
|
2015
Q4 | $11.9M | Buy |
21,900
+2,300
| +12% | +$1.25M | 0.08% | 229 |
|
|
2015
Q3 | $9.12M | Sell |
19,600
-7,900
| -29% | -$4.24M | 0.07% | 263 |
|
|
2015
Q2 | $14M | Sell |
27,500
-800
| -3% | -$390K | 0.12% | 192 |
|
|
2015
Q1 | $12.8M | Buy |
28,300
+18,600
| +192% | +$7.88M | 0.1% | 212 |
|
|
2014
Q4 | $3.98M | Buy |
9,700
+900
| +10% | +$354K | 0.03% | 379 |
|
|
2014
Q3 | $3.17M | Sell |
8,800
-26,200
| -75% | -$8.78M | 0.03% | 444 |
|
|
2014
Q2 | $9.89M | Buy |
35,000
+23,400
| +202% | +$6.94M | 0.08% | 244 |
|
|
2014
Q1 | $3.48M | Buy |
11,600
+900
| +8% | +$277K | 0.03% | 438 |
|
|
2013
Q4 | $2.94M | Buy |
10,700
+1,500
| +16% | +$431K | 0.03% | 432 |
|
|
2013
Q3 | $2.88M | Buy |
9,200
+8,100
| +736% | +$2.13M | 0.03% | 439 |
|
|
2013
Q2 | $247K | Buy |
+1,100
| New | +$256K | ﹤0.01% | 562 |
|
Other funds holding REGN
Korea Investment Corp's REGN Position: Q2 2026 in Review
Korea Investment Corp increased its Regeneron Pharmaceuticals (REGN) stake by 2.6% in Q2 2026, buying an estimated $1.29M and bringing the position to 74,955 shares worth $46.7M. The position accounts for 0.09% of the portfolio, ranked #213.
Korea Investment Corp first reported a position in REGN in Q2 2013 and has held it in 51 quarters since. The position peaked at $88.5M in Q1 2023. 1,332 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Korea Investment Corp held 74,955 shares of Regeneron Pharmaceuticals worth $46.7M as of Q2 2026.
- Korea Investment Corp bought 1,892 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $1.29M.
- Regeneron Pharmaceuticals made up 0.09% of Korea Investment Corp's portfolio in Q2 2026, its #213 holding.
- Korea Investment Corp first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 51 quarters since.
- Korea Investment Corp's Regeneron Pharmaceuticals position peaked at $88.5M in Q1 2023.
- 1,332 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Korea Investment Corp's 13F filing for Q2 2026, filed 12 Aug 2026.